Molecular analysis using next-generation platforms of non-small cell lung carcinoma for the development of prognostic profiles and new therapeutic tools.
Researcher | Principal Investigator Research Group Biomarkers and New Therapeutic Targets in Lung Cancer
Biomarkers and New Targets in Lung Cancer
Non-small cell lung carcinoma
- Convocation: Health R&D Projects. AES 2016
- Reference: PI16/01821
- Duration: 3 years
- Start date: January 1, 2017
- End date: December 31, 2019
- Funder: Instituto de Salud Carlos III y cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa”
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us